Benjamin Deitert

graph of relations

Publications

  1. 2023
  2. Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

    Stadler, J-C., Keller, L., Mess, C., Bauer, A. T., Koett, J., Geidel, G., Heidrich, I., Vidal-Y-Sy, S., Andreas, A., Stramaglia, C., Sementsov, M., Haberstroh, W., Deitert, B., Hoehne, I. L., Reschke, R., Haalck, T., Pantel, K., Gebhardt, C. & Schneider, S. W., 05.2023, In: J IMMUNOTHER CANCER. 11, 5, e006456.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors

    Heidrich, I., Deitert, B., Werner, S. & Pantel, K., 03.2023, In: CANCER METAST REV. 42, 1, p. 161-182 22 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  4. 2022
  5. Current and future clinical applications of ctDNA in immuno-oncology

    Stadler, J. C., Belloum, Y., Deitert, B., Sementsov, M., Heidrich, I., Gebhardt, C., Keller, L. & Pantel, K., 01.02.2022, In: CANCER RES. 82, 3, p. 349-358 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch